Heikki Jouttijärvi
Corporate Officer/Principal chez ADVERUM BIOTECHNOLOGIES, INC.
Profil
Heikki Jouttijärvi currently works at Adverum Biotechnologies, Inc., as Senior VP-Manufacturing & Supply Chain Management from 2023.
Mr. Jouttijärvi also formerly worked at Menlo Therapeutics, Inc., as Vice President-Technical Operations and Santen Pharmaceutical Co., Ltd., as VP, Head-Global External Manufacturing & Sourcing from 1999 to 2015.
Mr. Jouttijärvi received his graduate degree from the University of Helsinki.
Postes actifs de Heikki Jouttijärvi
| Sociétés | Poste | Début |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 25/06/2020 |
Anciens postes connus de Heikki Jouttijärvi
| Sociétés | Poste | Fin |
|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | 01/01/2015 |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Heikki Jouttijärvi
| University of Helsinki | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
